News
Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsRIDGEFIELD, Conn. , June 13 /- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient...
Medical Device and Diagnostic Industry Names Envoy Medical a Company to Watch
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsSAINT PAUL, Minn. , June 11 /- Envoy Medical Corporation has been named by Medical Device and Diagnostic Industry as one of the "50 Companies to Watch" in the medical device industry. Medical Device and Diagnostic Industry ("MD+DI"), a monthly magazine dedicated to the medical device and...
Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.
June 13, 2010 7:37 pm | by Bio-Medicine.Org | CommentsSTAMFORD, Conn. , June 11 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE ), today announced that it has entered into an agreement with Boston -based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds...
Children born after assisted reproduction at greater risk of congenital malformations
June 13, 2010 2:40 pm | by EurekAlert | Comments(European Society of Human Genetics) Couples considering undergoing assisted reproductive technology (ART) treatment should be informed about the increased risk of congenital malformation posed by the use of ART.
University Hospitals Case Medical Center cardiologists discover cancer risks in blood pressure meds
June 13, 2010 2:37 pm | by EurekAlert | Comments(University Hospitals Case Medical Center) University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs). This class of drugs is used by...
Small genetic variant can predict response to hepatitis C treatment
June 12, 2010 2:42 pm | by EurekAlert | Comments(European Society of Human Genetics) A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalized therapy for this difficult-to-treat disease.
Summary Information for: Ethicon? OMNEX? Surgical Sealant (250 & mu;l)
June 12, 2010 3:38 am | by U.S. Food & Drug Administration | CommentsLabeling, Approval Order, and Summary of Safety and Effectiveness for Ethicon? OMNEX? Surgical Sealant (250μl) (P060029).
FDA: Design Control Issues Remain Major Quality Assurance Concern
June 11, 2010 1:40 pm | by U.S. Food & Drug Administration | CommentsAlthough design control issues have not been cited often in recent warning letters, they remain a big concern for the FDA.
Cochlear Manufacturer Will Pay Nearly $1 Million to End Probe
June 11, 2010 1:40 pm | by U.S. Food & Drug Administration | CommentsA manufacturer of cochlear implants will pay nearly $1 million to resolve Justice Department claims that it paid kickbacks to physicians to prescribe its electronic hearing devices to Medicare and Medicaid patients from 1998 to 2003.
Cleveland Clinic invests in company that helps patients shop for care
June 11, 2010 1:39 pm | by Mass Device | CommentsThe Cleveland Clinic makes an investment in California internet search engine company Castlight Health Inc. to push transparency in healthcare pricing by offering consumers way to find cheaper care. By Mary Vanac Already an outspoken advocate for healthy living as a means to...
VCs want to have their cake and eat it too
June 11, 2010 10:39 am | by Mass Device | CommentsNot that there's anything wrong with that. The IN3 Investor's conference reveals a new breed of venture capitalists, who see lean as the new black. The new mantra of the venture capitalist is capital efficiency. I must have heard that six or seven times while attending the...
Nitride materials maker Kyma to expand with debt financing from NRDA
June 11, 2010 9:40 am | by I-Micronews | CommentsKyma Technologies Inc of Raleigh, NC, USA, which provides crystalline gallium nitride (GaN) and aluminum nitride (AlN) materials and related products and services, has announced its expansion plans along with new financing provided by Neuse River Development Authority (NRDA) of New Bern,...
IBM and MEMSIC bring ease of use to wireless sensors
June 11, 2010 9:40 am | by I-Micronews | CommentsMEMSIC adopts IBM software to enable organizations to more easily harness sensors and find patterns in ubiquitous data
Scientists strive to replace silicon with graphene on nanocircuitry
June 11, 2010 9:40 am | by I-Micronews | CommentsScientists have made a breakthrough toward creating nanocircuitry on graphene, widely regarded as the most promising candidate to replace silicon as the building block of transistors.
3M completes MTI PolyFab acquisition
June 11, 2010 9:10 am | CommentsManufacturing conglomerate 3M Co. said Friday it completed the acquisition of MTI PolyFab Inc., a Canadian manufacturer of noise and vibration reduction technology for airplanes.The $24 million deal was announced in March.3M said MTI PolyFab products will complement those of its subsidiary...
